Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>PI3K / Akt / mTOR>GSK-3 inhibitors>LY2090314
LY2090314
  • LY2090314

LY2090314 NEW

Price $39 $92 $147
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-11-04

Product Details

Product Name: LY2090314 CAS No.: 603288-22-8
Purity: 99.91% Supply Ability: 10g
Release date: 2025/11/04

Product Introduction

Bioactivity

NameLY2090314
DescriptionLY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.
In vivoLY2090314 enhances the efficacy of cisplatin and carboplatin in solid tumor cancer xenografts. [1]
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 93 mg/mL (181.45 mM), Sonication is recommended.
Ethanol : 2 mg/mL (3.9 mM), Heating is recommended.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (3.9 mM), Sonication is recommended.
KeywordsLY-2090314 | LY2090314 | LY 2090314 | Inhibitor | inhibit | GSK-3β | GSK-3α | GSK-3 | GSK3 | Glycogen synthase kinase-3 | Glycogen synthase kinase 3
Inhibitors RelatedPHA-767491 | Cromolyn sodium | GSK 3 Inhibitor IX | CHIR-99021 | AT7519 | 5-Bromoindole | 4-Chloro-2'-bromoacetophenone | SNS-032 | CHIR-99021 HCl | GSK-3 Inhibitor 5 | MeBIO | 1-Azakenpaullone
Related Compound LibrariesFailed Clinical Trials Compound Library | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Neuroprotective Compound Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$/
Anhui Ruihan Technology Co., Ltd
2023-08-21

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY